Herpesvirus Target Considerations for the Design of Antiviral Agents (original) (raw)
Antiviral Activity of S-7HNa on the Infectivity and Replication of Herpes Simplex Virus Type 1 in Cultured Cells
elisabetta tonoli
Journal of Chemotherapy, 1995
View PDFchevron_right
Search of Inhibitors of Herpes Viral Replication: 30 Years After Acyclovir
A. Korovina
Biotechnologia Acta, 2013
View PDFchevron_right
Characterization of an Oncolytic Herpes Simplex Virus Drug Candidate
Prem Thapa
Journal of Pharmaceutical Sciences, 2015
View PDFchevron_right
Human herpes simplex virus: Life cycle and development of inhibitors
Marina Kukhanova
Biochemistry (Moscow), 2014
View PDFchevron_right
Broad-spectrum non-nucleoside inhibitors of human herpesviruses
Ayantika Ghosh
Antiviral research, 2015
View PDFchevron_right
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle
roberto burioni
Antiviral research, 2018
View PDFchevron_right
Identification of antiviral compounds against equid herpesvirus‐1 using Real‐Time Cell Analysis: screening of 2,891 molecules
Esam Azhar
Equine Veterinary Journal, 2021
View PDFchevron_right
Molecular Conformation Correlation to Activity Against Herpes Simplex Virus of (E)-5-(2-Bromovi-nyl)-2’-Deoxycytidine and 5-Methoxymethyl-2’-Deoxycyti-dine Analogs: Short-Review
Wajdi M ZOGHAIB
Biomedical Journal of Scientific & Technical Research, 2019
View PDFchevron_right
The Role of Pyrazolopyridine Derivatives on Different Steps of Herpes Simplex Virus Type-1 In Vitro Replicative Cycle
Milene Miranda
International Journal of Molecular Sciences
View PDFchevron_right
Stability and anti-tumor effect of oncolytic herpes simplex virus type 2
Zhifeng Ning
Oncotarget, 2018
View PDFchevron_right
The potential antiviral activity of a novel pyrimidine derivative against Herpes Simplex Virus type-1 (HSV-1)
Samir awad
Systematic Reviews in Pharmacy, 2020
View PDFchevron_right
Antiviral activity of the 3′;-amino derivative of (E)-5-(2-bromovinyl)-2′;-deoxyuridine
Johan Descamps
Biochemical Journal, 1983
View PDFchevron_right
Analysis of toxic and mutagenic activities of antiherpesvirus nucleosides against HeLa cells and herpes simplex virus type 1
T. Suzutani
Mutation research, 1992
View PDFchevron_right
Chemistry and anti-herpes simplex virus type 1 evaluation of cycloSal-nucleotides of acyclic nucleoside analogues
Alessandro Jordão
1998
View PDFchevron_right
Effects of Acyclovir, Oxetanocin-G, and Carbocyclic Oxetanocin-G in Combinations on the Replications of Herpes Simplex Virus Type 1 and Type 2 in Vero Cells
T. Suzutani
The Tohoku Journal of Experimental Medicine, 1992
View PDFchevron_right
Antiviral effects of 6-diazo-5-oxo-l-norleucin on replication of herpes simplex virus type 1
Hana Kabickova
Antiviral Research, 1997
View PDFchevron_right
Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells
T. Suzutani
Antimicrobial Agents and Chemotherapy, 1988
View PDFchevron_right
Antiviral Research 2014.pdf
Debprasad Chattopadhyay
View PDFchevron_right
In vitro inhibition of human herpesvirus-6 by phosphonoformate
Carl Saxinger
Journal of Virological Methods, 1988
View PDFchevron_right
Elucidation of the mechanism of anti-herpes action of two novel semisynthetic cardenolide derivatives
Cláudia Maria Oliveira Simões
Archives of Virology
View PDFchevron_right
(E)-N-(3,4-dimethylisoxazol-5-yl)-4-((4-hydroxy-2-oxo-2H-chromen-3-yl) diazenyl)Benzenesulfonamide; A New Synthetic Anti-Herpetic Agent for HSV-1
brij tiwari
Evergreen, 2021
View PDFchevron_right
Inhibition of B Virus (Macacine herpesvirus 1) by Conventional and Experimental Antiviral Compounds
Julia Hilliard
Antimicrobial Agents and Chemotherapy, 2010
View PDFchevron_right
Comparison of the Antiviral Effects of 5-Methoxymethyl-deoxyuridine with 5-Iododeoxyuridine, Cytosine Arabinoside, and Adenine Arabinoside
Lorne Babiuk
Antimicrobial Agents and Chemotherapy, 1975
View PDFchevron_right
Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423
Leen De Bolle
Biochemical Pharmacology, 2004
View PDFchevron_right
A new antiviral screening method that simultaneously detects viral replication, cell viability, and cell toxicity
gili joseph
Journal of Virological Methods, 2014
View PDFchevron_right
Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis
Agnès Gautheret-dejean
Cytometry, 2000
View PDFchevron_right
Antiviral Chemistry Chemotherapy.pdf
Dr D Chattopadhyay
View PDFchevron_right
Emerging therapies for herpes viral infections (types 1 – 8)
Karl Beutner
Expert Opinion on Emerging Drugs, 2004
View PDFchevron_right
Biologic properties of human herpesvirus 7 Strain SB
Raymond Schinazi
Virus Research, 1997
View PDFchevron_right
Antiviral drug resistance and helicase–primase inhibitors of herpes simplex virus
Subhajit Biswas
Drug Resistance Updates, 2011
View PDFchevron_right
Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate
Jens Milbradt
Journal of Clinical Virology, 2009
View PDFchevron_right